Cumberland Pharmaceuticals Inc
CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31
Reports and events: 326 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-11-1317:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-014296 |
| 2018-11-0616:57 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-18-013796 |
| 2018-10-1917:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-18-012707 |
| 2018-10-0117:26 ET | 8-K | 8.01 Other events | 0001628280-18-012188 |
| 2018-09-2117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-18-012030 |
| 2018-08-1417:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-011135 |
| 2018-08-1417:12 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001628280-18-011131 |
| 2018-08-0317:03 ET | 8-K | 8.01 Other events | 0001628280-18-010464 |
| 2018-06-0117:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-18-007513 |
| 2018-05-0917:13 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001628280-18-006417 |
| 2018-05-0817:06 ET | 8-K | 2.02 Results of operations | 0001628280-18-006275 |
| 2018-04-2717:01 ET | 8-K | 5.07 Shareholder vote results | 0001628280-18-005273 |
| 2018-04-1317:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-18-004264 |
| 2018-03-3016:59 ET | 8-K | 8.01 Other events | 0001628280-18-003872 |
| 2018-03-1617:00 ET | 8-K | 8.01 Other events | 0001628280-18-003317 |
| 2018-03-1517:45 ET | DEF 14A | Proxy statementPeriod 2018-04-24 | 0001628280-18-003200 |
| 2018-03-0916:58 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001628280-18-003034 |
| 2018-03-0916:55 ET | 8-K | 2.02 Results of operations | 0001628280-18-003033 |
| 2018-02-0217:07 ET | 8-K | 8.01 Other events | 0001628280-18-000933 |
| 2017-12-0817:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-17-012273 |
| 2017-11-0817:12 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001628280-17-011224 |
| 2017-11-0817:09 ET | 8-K | 2.02 Results of operations | 0001628280-17-011222 |
| 2017-09-2917:07 ET | 8-K | 8.01 Other events | 0001628280-17-009553 |
| 2017-08-1117:01 ET | 8-K | 8.01 Other events | 0001628280-17-008600 |
| 2017-08-0917:04 ET | 8-K | 2.02 Results of operations | 0001628280-17-008471 |
| 2017-08-0917:01 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001628280-17-008470 |
| 2017-08-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001628280-17-007877 |
| 2017-08-0116:59 ET | 8-K | 8.01 Other events | 0001628280-17-007773 |
| 2017-07-1017:10 ET | 8-K | 8.01 Other events | 0001628280-17-006984 |
| 2017-05-1517:00 ET | 8-K | 2.02 Results of operations | 0001628280-17-005581 |
| 2017-05-1516:59 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001628280-17-005580 |
| 2017-04-2817:00 ET | 8-K | 8.01 Other events | 0001628280-17-004500 |
| 2017-04-2816:58 ET | 8-K | 5.07 Shareholder vote results | 0001628280-17-004499 |
| 2017-03-3117:22 ET | 8-K | 8.01 Other events | 0001628280-17-003253 |
| 2017-03-2217:27 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-17-002800 |
| 2017-03-1617:07 ET | DEF 14A | Proxy statementPeriod 2017-04-25 | 0001628280-17-002649 |
| 2017-03-1617:03 ET | 8-K | 4.01 Change of auditor | 0001628280-17-002647 |
| 2017-03-1318:02 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001628280-17-002485 |
| 2017-03-1017:06 ET | 8-K | 2.02 Results of operations | 0001628280-17-002482 |
| 2017-02-1017:00 ET | 8-K | 8.01 Other events | 0001628280-17-001119 |
| 2017-02-0317:00 ET | 8-K | 8.01 Other events | 0001628280-17-000870 |
| 2017-01-2017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-17-000328 |
| 2017-01-1317:00 ET | 8-K | 8.01 Other events | 0001628280-17-000232 |
| 2016-11-2117:15 ET | 8-K | 8.01 Other events | 0001628280-16-021585 |
| 2016-11-0317:17 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001628280-16-020795 |
| 2016-11-0317:14 ET | 8-K | 2.02 Results of operations | 0001628280-16-020794 |
| 2016-09-3017:21 ET | 8-K | 8.01 Other events | 0001628280-16-019884 |
| 2016-09-1617:06 ET | 8-K | 8.01 Other events | 0001628280-16-019619 |
| 2016-08-2616:59 ET | 8-K | 8.01 Other events | 0001628280-16-019270 |
| 2016-08-0517:08 ET | 8-K | 2.02 Results of operations | 0001628280-16-018626 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:05 ET. Listed shows no prices and gives no investment advice.